Showing 1,101 - 1,120 results of 9,521 for search '(( six ((mean decrease) OR (nn decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 0.51s Refine Results
  1. 1101
  2. 1102

    Nilotinib decreases viability and proliferation of HEI-193 cells in a dose-dependent manner. by Nesrin Sabha (127278)

    Published 2013
    “…<p>HEI-193 cells grown in PDGF-BB or GM were evaluated after 5 days of treatment with 0, 3, 5, 10 or 20 µM nilotinib. Shown, mean value of six technical replicates. *denotes significant value (<i>p</i><0.05), **denotes significant value (p<0.005) (A) Nilotinib decreased absorbance on MTS viability assay in both growth conditions. …”
  3. 1103

    Simvastatin decreases cerebral vasospasm of the middle cerebral artery and reduces microthromboemboli after SAH. by Mohammed Sabri (355717)

    Published 2013
    “…Both pre-SAH and post-SAH treatment with simvastatin significantly decrease microthromboemboli in both cerebral cortex (<i>P</i><0.001) and hippocampus (<i>P</i><0.01) as compared to vehicle treated group. …”
  4. 1104
  5. 1105
  6. 1106

    Performance of the response detection algorithm at detecting simulated increases versus decreases in firing rate. by Bettina C. Schwab (9515382)

    Published 2020
    “…That bias disappeared for larger response sizes (>100% of baseline). Box plots show the distributions of response in our recorded data plotted separately for increases and decreases for each cell type. …”
  7. 1107

    AMPs are increased in lesional HS, but DCD and other sweat-gland associated proteins are decreased. by Margaret Coates (6058580)

    Published 2019
    “…Genes highlighted in blue are downregulated genes of interest; genes highlighted in red are upregulated genes of interest. While <i>DCD</i> is downregulated in HS lesional skin, many other AMPs and interferon-associated molecules are enriched in lesional HS. …”
  8. 1108
  9. 1109
  10. 1110

    Stimulation of α2-adrenergic receptors inhibits hippocampal precursor activity and decreases neurogenesis. by Dhanisha J. Jhaveri (577341)

    Published 2014
    “…The number of DCX-positive cells was also significantly reduced in guanabenz-treated mice (F). (mean±SEM, *<i>p</i><0.05, **<i>p</i><0.01, ***<i>p</i><0.01).…”
  11. 1111
  12. 1112

    Outcome variable descriptive statistics. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  13. 1113

    Demographic & job characteristics. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  14. 1114

    Training feedback. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  15. 1115

    Study flow. by Kristen S. Regenauer (13842386)

    Published 2024
    “…SU stigma significantly decreased (<i>F</i>(1,16) = 18.94, <i>p</i> < 0.001, η<sub>p</sub><sup>2</sup> = 0.54). …”
  16. 1116

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<b><i>Results:</i></b> Mean ± SE serum K decreased (maximum change per corresponding day, 0.6 ± 0.2 mEq/l, p = 0.009) and fecal K increased 58% on patiromer compared with the pretreatment week. …”
  17. 1117
  18. 1118
  19. 1119
  20. 1120